These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary. Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562 [TBL] [Abstract][Full Text] [Related]
4. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221 [TBL] [Abstract][Full Text] [Related]
5. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival. Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937 [TBL] [Abstract][Full Text] [Related]
6. The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Frede S; Freitag P; Otto T; Heilmaier C; Fandrey J Cancer Res; 2005 Jun; 65(11):4690-7. PubMed ID: 15930287 [TBL] [Abstract][Full Text] [Related]
7. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo. Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression. Kato N; Motoyama T Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways]. Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551 [TBL] [Abstract][Full Text] [Related]
10. Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Guo Y; Nemeth J; O'Brien C; Susa M; Liu X; Zhang Z; Choy E; Mankin H; Hornicek F; Duan Z Clin Cancer Res; 2010 Dec; 16(23):5759-69. PubMed ID: 20699329 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387 [TBL] [Abstract][Full Text] [Related]
13. The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Shi J; Schmitt-Talbot E; DiMattia DA; Dullea RG Inflamm Res; 2004 Aug; 53(8):377-89. PubMed ID: 15316669 [TBL] [Abstract][Full Text] [Related]
14. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091 [TBL] [Abstract][Full Text] [Related]
15. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [TBL] [Abstract][Full Text] [Related]
16. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757 [TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
18. Th-1/Th-2 type cytokine profiles of pig T-cells cultured with antigen-treated monocyte-derived dendritic cells. Raymond CR; Wilkie BN Vaccine; 2004 Feb; 22(8):1016-23. PubMed ID: 15161079 [TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of TGF-bêta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma. Toutirais O; Chartier P; Dubois D; Bouet F; Lévêque J; Catros-Quemener V; Genetet N Eur Cytokine Netw; 2003; 14(4):246-55. PubMed ID: 14715418 [TBL] [Abstract][Full Text] [Related]
20. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Hao C; Parney IF; Roa WH; Turner J; Petruk KC; Ramsay DA Acta Neuropathol; 2002 Feb; 103(2):171-8. PubMed ID: 11810184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]